Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

ONC lauds Ohio, Kentucky and Maine for health IT usage

Ohio, Kentucky and Maine were recognized during the Office of the National Coordinator of Health IT's (ONC) annual meeting on Dec. 12 as the states using health IT in ways that will make a meaningful difference in healthcare for patients.

Tenn Gov. on the fence about state insurance exchange

Tennessee Gov. Bill Haslam (R) announced the state will not operate a state-based healthcare exchange under the Patient Protection and Affordable Care Act.

KLAS: Use of BI tools increasing

Providers are experiencing increased knowledge dissemination and end-user adoption within their organizations as a result of work with their business intelligence (BI) tools. According to the KLAS report, Business Intelligence: Influencing Change?, measuring and improving performance and outcomes are at the forefront of the 381 surveyed providers' BI efforts today and will continue to be so in the near future.

Calif. market reports show gaps in health reform prep

New market studies of the San Francisco and Fresno areas conducted by the Center for Studying Health System Change (HSC) offer a stark contrast—particularly in preparations for health reform—between one of the most affluent and poorest regions of the state.

Medical device tax late payments to be waived for most of 2013

The Internal Revenue Service (IRS) will waive late payment penalties on the medical device tax for the first nine months of 2013, according to new regulations. However, late payment penalties will only be waived in situations where a company has reasonable cause.

From Good to Great: How Advocate Good Samaritan Hospital Achieved Excellence

House

Nearly a decade ago, when David Fox assumed the role of president and CEO of Advocate Good Samaritan Hospital, Downers Grove, Illinois, the Malcolm Baldrige National Quality Award-winning hospital held a somewhat moderate quality ranking. Employee satisfaction ranked in the 46th percentile and its physician hospital organization (PHO) was paying

Change for the Better: Cleveland Clinic Improves the Patient Experience

House

After Delos “Toby” Cosgrove, MD, CEO of Cleveland Clinic in Cleveland, Ohio, made a presentation about the hospital’s record of operational excellence at Harvard Business School in Cambridge, Massachusetts, several years ago, a student asked him what the hospital was doing about teaching its physicians empathy.

Those Troublesome HCAHPS Scores

House

The only way to ace the HCAHPS is to go beyond caring for patients and make them believe you really do care for them. This journey is just beginning, and it is likely to turn up some interesting strategies along the way—not to mention a good deal of grumbling about the inherent unfairness of being judged on soft skills rather than science and

Displaying 7753 - 7760 of 8456

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.